The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet
Background: This study tested the hypothesis that Entresto could safely and effectively preserve heart and kidney function in rats with cardiorenal syndrome (CRS) induced by 5/6 nephrectomy and intra-peritoneal doxorubicin administration (accumulated dosage up to 7.5 mg/kg) together with daily high-...
Main Authors: | Chih-Chao Yang, Yen-Ta Chen, Chih-Hung Chen, Yi-Chen Li, Pei-Lin Shao, Then-Hung Huang, Yi-Ling Chen, Cheuk-Kwan Sun, Hon-Kan Yip |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332219305931 |
Similar Items
-
Entresto protected the cardiomyocytes and preserved heart function in cardiorenal syndrome rat fed with high-protein diet through regulating the oxidative stress and Mfn2-mediated mitochondrial functional integrity
by: Jui-Ning Yeh, et al.
Published: (2021-12-01) -
Early treatment with combination of SS31 and entresto effectively preserved the heart function in doxorubicin-induced dilated cardiomyopathic rat
by: Jui-Ning Yeh, et al.
Published: (2021-09-01) -
Cost-Effectiveness and Formulary Evaluation: Imaginary Worlds and Entresto Claims in Heart Failure
by: Paul C Langley
Published: (2016-09-01) -
Early administration of empagliflozin preserved heart function in cardiorenal syndrome in rat
by: Chih-Chao Yang, et al.
Published: (2019-01-01) -
Síndrome cardiorenal
by: V. Marcelo Llancaqueo, Dr.
Published: (2010-07-01)